全文获取类型
收费全文 | 15951篇 |
免费 | 800篇 |
国内免费 | 123篇 |
专业分类
耳鼻咽喉 | 362篇 |
儿科学 | 270篇 |
妇产科学 | 169篇 |
基础医学 | 2010篇 |
口腔科学 | 474篇 |
临床医学 | 1038篇 |
内科学 | 3985篇 |
皮肤病学 | 253篇 |
神经病学 | 1150篇 |
特种医学 | 514篇 |
外科学 | 2907篇 |
综合类 | 61篇 |
一般理论 | 1篇 |
预防医学 | 548篇 |
眼科学 | 221篇 |
药学 | 914篇 |
中国医学 | 36篇 |
肿瘤学 | 1961篇 |
出版年
2023年 | 92篇 |
2022年 | 55篇 |
2021年 | 266篇 |
2020年 | 167篇 |
2019年 | 230篇 |
2018年 | 305篇 |
2017年 | 264篇 |
2016年 | 339篇 |
2015年 | 338篇 |
2014年 | 456篇 |
2013年 | 543篇 |
2012年 | 931篇 |
2011年 | 960篇 |
2010年 | 549篇 |
2009年 | 501篇 |
2008年 | 807篇 |
2007年 | 891篇 |
2006年 | 915篇 |
2005年 | 941篇 |
2004年 | 858篇 |
2003年 | 806篇 |
2002年 | 752篇 |
2001年 | 414篇 |
2000年 | 448篇 |
1999年 | 415篇 |
1998年 | 190篇 |
1997年 | 130篇 |
1996年 | 139篇 |
1995年 | 123篇 |
1994年 | 112篇 |
1993年 | 105篇 |
1992年 | 302篇 |
1991年 | 228篇 |
1990年 | 235篇 |
1989年 | 209篇 |
1988年 | 212篇 |
1987年 | 198篇 |
1986年 | 203篇 |
1985年 | 166篇 |
1984年 | 121篇 |
1983年 | 109篇 |
1981年 | 47篇 |
1980年 | 54篇 |
1979年 | 88篇 |
1978年 | 63篇 |
1977年 | 49篇 |
1974年 | 63篇 |
1972年 | 50篇 |
1970年 | 46篇 |
1969年 | 61篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Oka Emiko Ueda Yutaka Nagase Yoshikazu Sawada Masaaki Egawa-Takata Tomomi Yagi Asami Kakuda Mamoru Nakagawa Satoshi Hiramatsu Kosuke Miyoshi Ai Kobayashi Eiji Kimura Toshihiro Kimura Tadashi 《International journal of clinical oncology / Japan Society of Clinical Oncology》2022,27(8):1356-1363
International Journal of Clinical Oncology - In Japan, the government suspended HPV vaccine recommendation in 2013, resulting in dropping vaccination uptake to almost zero. We conducted four serial... 相似文献
2.
Aoki Yoichi Kanao Hiroyuki Fusegi Atsushi Omi Makiko Okamoto Sanshirou Tanigawa Terumi Nomura Hidetaka Omatsu Kohei Tonooka Akiko 《International journal of clinical oncology / Japan Society of Clinical Oncology》2022,27(9):1499-1506
International Journal of Clinical Oncology - Lymph node metastasis is a critical prognostic factor in cervical cancer. Considering the potential complications of lymphadenectomy and desirability of... 相似文献
3.
Yamadera Masato Shinto Eiji Nagata Ken Shiraishi Takehiro Kajiwara Yoshiki Mochizuki Satsuki Okamoto Koichi Kishi Yoji Ueno Hideki 《International journal of clinical oncology / Japan Society of Clinical Oncology》2022,27(4):756-764
International Journal of Clinical Oncology - In colorectal cancer, tumor budding is highlighted as both a prognostic indicator and a predictor of chemosensitivity. However, tumor budding has a... 相似文献
4.
Shinichi Tsuruta Kenichi Kohashi Yuichi Yamada Minako Fujiwara Yutaka Koga Eikichi Ihara Yoshihiro Ogawa Eiji Oki Masafumi Nakamura Yoshinao Oda 《Cancer science》2020,111(3):1008-1019
ARID1A, one of the subunits in SWI/SNF chromatin remodeling complex, is frequently mutated in gastric cancers with microsatellite instability (MSI). The most frequent MSI in solid‐type poorly differentiated adenocarcinoma (PDA) has been reported, but the SWI/SNF complex status in solid‐type PDA is still largely unknown. We retrospectively analyzed 54 cases of solid‐type PDA for the expressions of mismatch repair (MMR) proteins (MLH1, PMS2, MSH2, and MSH6), SWI/SNF complex subunits (ARID1A, INI1, BRG1, BRM, BAF155, and BAF170) and EBER, and mutations in KRAS and BRAF. We analyzed 40 cases of another histological type of gastric cancer as a control group. The solid‐type PDAs showed coexisting glandular components (76%), MMR deficiency (39%), and complete/partial loss of ARID1A (31%/7%), INI1 (4%/4%), BRG1 (48%/30%), BRM (33%/33%), BAF155 (13%/41%), and BAF170 (6%/2%), EBER positivity (4%), KRAS mutation (2%), and BRAF mutation (2%). Compared to the control group, MMR deficiency and losses of ARID1A, BRG1, BRM, and BAF155 were significantly frequent in solid‐type PDAs. Mismatch repair deficiency was associated with the losses of ARID1A, BRG1, and BAF155 in solid‐type PDAs. In the MMR‐deficient group, solid components showed significantly more frequent losses of ARID1A, BRG1, BRM, and BAF155 compared to glandular components (P = .0268, P = .0181, P = .0224, and P = .0071, respectively). In the MMR‐proficient group, solid components showed significantly more frequent loss of BRG1 compared to glandular components (P = .012). In conclusion, solid‐type PDAs showed frequent losses of MMR proteins and the SWI/SNF complex. We suggest that loss of the SWI/SNF complex could induce a morphological shift from differentiated‐type adenocarcinoma to solid‐type PDA. 相似文献
5.
Hou Chongxian Ishi Yukitomo Motegi Hiroaki Okamoto Michinari Ou Yafei Chen Jiawei Yamaguchi Shigeru 《Journal of neuro-oncology》2019,145(2):201-210
Journal of Neuro-Oncology - Overexpression of CD44 has been detected in many types of tumor tissues. Moreover, CD44 is recognized as a cancer stem cell marker for many cancers. However, the... 相似文献
6.
Tomoya Kurokawa Takuya Nakagawa Keisuke Matsusaka Masaki Fukuyo Masato Mima Kiyoshi Misawa Bahityar Rahmutulla Jun‐ichiro Ikeda Toyoyuki Hanazawa Yoshitaka Okamoto Atsushi Kaneda 《Cancer science》2020,111(4):1407-1416
Irradiation, or chemoradiotherapy, is a curative treatment for oropharyngeal squamous cell carcinoma (OPSCC). Its invasiveness, however, can often negate its efficacy. Therefore, developing methods to predict which patients would benefit from irradiation is urgent. Promoter DNA hypermethylation was recently reported to correlate with favorable OPSCC prognosis. It is still unclear, however, whether there is an association between promoter DNA methylation and response to irradiation. In this study, we analyzed DNA methylation in the specimens from 40 OPSCC patients who had undergone irradiation, using the Infinium assay. Our results showed significant correlation between high levels of promoter DNA methylation and better response to treatment (P < 0.01). We used the 10 most differentially‐methylated genes between responders and non–responders to develop a panel of predictive markers for efficacy. Our panel had high sensitivity, specificity and accuracy (92%, 93% and 93%, respectively). We conducted pyrosequencing to quantitatively validate the methylation levels of 8 of the 10 marker genes (ROBO1, ULK4P3, MYOD1, LBX1, CACNA1A, IRX4, DPYSL3 and ELAVL2) obtained by Infinium. The validation by pyrosequencing showed that these 8 genes had a high prediction performance for the training set of 40 specimens and for a validation set of 35 OPSCC specimens, showing 96% sensitivity, 89% specificity and 94% accuracy. Methylation of these markers correlated significantly with better progression‐free and overall survival rates, regardless of human papillomavirus status. These results indicate that increased DNA methylation is associated with better responses to irradiation therapy and that DNA methylation can help establish efficacy prediction markers in OPSCC. 相似文献
7.
Ryota Kobayashi Yuto Hashimoto Hiroyuki Hatakeyama Takanobu Okamoto 《Clinical and experimental hypertension (New York, N.Y. : 1993)》2019,41(2):123-129
The aim of this study was to investigate the acute repeated bouts of aerobic exercise decrease leg arterial stiffness. However, the influence of repeated bouts of aerobic exercise on arterial stiffness after glucose ingestion is unknown. The present study investigates the acute effects of repeated bouts of aerobic exercise on arterial stiffness after the 75-g oral glucose tolerance test (OGTT). Ten healthy young men (age, 23.2 ± 0.9 years) performed repeated bouts of aerobic exercise trial (RE, 65% peak oxygen uptake; two 15 min bouts of cycling performed 20 min apart) and control trial (CON, seated and resting in a quiet room) at 80 min before the 75-g OGTT on separate days in a randomized, controlled crossover fashion. Carotid-femoral (aortic) and femoral-ankle (leg) pulse wave velocity, carotid augmentation index, brachial and ankle blood pressure, heart rate and blood glucose and insulin levels were measured before (baseline) and 30, 60 and 120 min after the 75-g OGTT. Leg pulse wave velocity, ankle systolic blood pressure and blood glucose levels increased from baseline after the 75-g OGTT in the CON trial, but not in the RE trial. The present findings indicate that acute repeated bouts of aerobic exercise before glucose ingestion suppress increases in leg arterial stiffness following glucose ingestion.
Abbreviations: RE trial repeated bouts of aerobic exercise trial; CON trial control trial; BG blood glucose; VO2peak peak oxygen uptake; PWV Pulse wave velocity; AIx carotid augmentation index; BP blood pressure; HR heart rate; CVs coefficients of variation; RPE Ratings of perceived exertion; SE standard error 相似文献
8.
Mizuho Kondo-Ando Yusuke Seino Risa Morikawa Kana Negi Hidechika Todoroki Tsukasa Kawakami Yohei Asada Ryo Yoshimoto Chika Tanaka Keiko Okamoto Atsushi Masuda Eisuke Tomatsu Izumi Hiratsuka Yasumasa Yoshino Wakako Maki Ayako Kakita Megumi Shibata Takeshi Takayanagi Atsushi Suzuki 《Journal of diabetes and its complications》2019,33(11):107415
AimsThe aim of this study is to investigate the effects of a low-carbohydrate staple food (i.e., low-carbohydrate bread) on glucose and lipid metabolism and pancreatic and enteroendocrine hormone secretion in comparison with meals containing normal-carbohydrate bread, without consideration of the carbohydrate content of the side dishes.MethodsT2DM patients (n = 41) were provided meals containing low-carbohydrate bread (LB) together with side dishes or normal-carbohydrate bread (NB) together with side dishes every other day as a breakfast. Blood glucose levels were evaluated by using a continuous glucose monitoring system; blood samples were collected before and 1 and 2 h after the breakfast.ResultsPostprandial blood glucose levels, plasma insulin, plasma glucose-dependent insulinotropic polypeptide (GIP) and plasma triglyceride were significantly lower and plasma glucagon levels were significantly higher in LB compared with those in NB. Plasma glucagon-like peptide-1 (GLP-1) levels did not differ in the LB and NB groups.ConclusionsThese results indicate that changing only the carbohydrate content of the staple food has benefits on glucose and lipid metabolism in T2DM patients concomitant with the decrease of insulin and GIP secretion, which ameliorate body weight gain and insulin resistance. 相似文献
9.
Hirokazu Miki Shingen Nakamura Masahiro Oura Hirofumi Hamano Kenji Ikuta Naoto Okada Yasunobu Okamoto Kimiko Sogabe Mamiko Takahashi Masami Iwasa Kengo Udaka Takeshi Harada Kiyoe Kurahashi Shiro Fujii Sumiko Yoshida Kumiko Kagawa Itsuro Endo Ken-ichi Aihara Masahiro Abe 《British journal of haematology》2019,186(2):355-358
10.
Mayu Shiomi Shinya Matsuzaki Satoshi Serada Koji Matsuo Chihiro Mizuta-Odani Mariko Jitsumori Ruriko Nakae Satoko Matsuzaki Satoshi Nakagawa Kosuke Hiramatsu Ai Miyoshi Eiji Kobayashi Toshihiro Kimura Yutaka Ueda Kiyoshi Yoshino Tetsuji Naka Tadashi Kimura 《Cancer science》2021,112(9):3655-3668
This study aimed to investigate the cytotoxicity of a cluster of differentiation 70 antibody-drug conjugate (CD70-ADC) against ovarian cancer in in vitro and in vivo xenograft models. CD70 expression was assessed in clinical samples by immunohistochemical analysis. Western blotting and fluorescence-activated cell sorting analyses were used to determine CD70 expression in the ovarian cancer cell lines A2780 and SKOV3, and in the cisplatin-resistant ovarian cancer cell lines A2780cisR and SKOV3cisR. CD70 expression after cisplatin exposure was determined in A2780 cells transfected with mock- or nuclear factor (NF)-κB-p65-small interfering RNA. We developed an ADC with an anti-CD70 monoclonal antibody linked to monomethyl auristatin F and investigated its cytotoxic effect. We examined 63 ovarian cancer clinical samples; 43 (68.3%) of them expressed CD70. Among patients with advanced stage disease (n = 50), those who received neoadjuvant chemotherapy were more likely to exhibit high CD70 expression compared to those who did not (55.6% [15/27] vs 17.4% [4/23], P < .01). CD70 expression was confirmed in A2780cisR, SKOV3, and SKOV3cisR cells. Notably, CD70 expression was induced after cisplatin treatment in A2780 mock cells but not in A2780-NF-κB-p65-silenced cells. CD70-ADC was cytotoxic to A2780cisR, SKOV3, and SKOV3cisR cells, with IC50 values ranging from 0.104 to 0.341 nmol/L. In A2780cisR and SKOV3cisR xenograft models, tumor growth in CD70-ADC treated mice was significantly inhibited compared to that in the control-ADC treated mice (A2780cisR: 32.0 vs 1639.0 mm3, P < .01; SKOV3cisR: 232.2 vs 584.9 mm3, P < .01). Platinum treatment induced CD70 expression in ovarian cancer cells. CD70-ADC may have potential therapeutic implications in the treatment of CD70 expressing ovarian cancer. 相似文献